Ann: Appendix 4E and Unaudited Preliminary Report, page-21

Rubbish speculation. Nice bpharma. Of course it is speculation.

My old man was asking me about share prices an hour before he passed. While the brain is still working it keeps thinking about what it always has.

That $350k purchase was extraordinary, especially with the delta between what he paid and this CR. The money came from somewhere. Suggest given a family business, he got some help to purchase thru the family plus they agreed to up his rem if he bought on market and supported the price. Yes just speculation but must have been something more in it for him given he already has so much of his wealth tied up here.

The CR was always going to be at a hefty discount with current market conditions. Think tactics like this have helped support the price and resulted in less of a fire sale than otherwise.

however they have managed to keep the SP from the 90% drops we have seen on other clinical bios, they have done well.